Microenvironmental conditions and serum availability alter primary human macrophage NF-κB inflammatory response and function
Macrophages are central to innate immunity and are routinely used in vitro to examine molecular mechanisms contributing to innate immune signaling. However, there is a lack of consensus within the field for optimal in vitro culturing methods, and it is not well understood whether differences in culture conditions produce incongruent outcomes. Here, we compared the effects of commonly used culture medium compositions on TLR4-mediated proinflammatory activity in primary human monocyte-derived macrophages (hMDMs) isolated from healthy blood donors. hMDMs were cultured in fetal bovine serum (FBS)-containing or FBS-free conditions in either Dulbecco's Modified Eagle Medium (DMEM), RPMI, or in Macrophage-Serum Free Medium (M-SFM). Lipopolysaccharide-mediated immune response was measured through nuclear factor κB activation and cytokine and chemokine secretion, which were muted in M-SFM cultures compared with DMEM and RPMI cultures. FBS supplementation increased total cytokine secretion in response to lipopolysaccharide but also showed higher baseline secretion, suggesting a proinflammatory phenotype. Moreover, M-SFM cultures exhibited less phagocytosis compared with DMEM and RPMI cultures. Morphologic analysis of unstimulated hMDMs revealed the highest cell area and length-to-width ratio in M-SFM compared with DMEM or RPMI cultures. FBS-free and M-SFM conditions produced distinct transcriptional profiles compared with media supplemented with FBS, most notably in cell cycle pathways and lipid homeostasis, respectively. Overall, DMEM and RPMI produce comparable morphologic and functional results, albeit with some small differences, while M-SFM produces a muted inflammatory response in macrophages. These data demonstrate that in vitro microenvironment drives differential inflammatory outcomes in human macrophages and is a critical component of experimental design in this cell type.
Authors
- Will Dampier (ORCID: https://orcid.org/0000-0002-3362-2610)
- Meng Niu (ORCID: https://orcid.org/0000-0003-1055-3728)
- Peter J. Gaskill (ORCID: https://orcid.org/0000-0003-0095-5424)
- Brian J. Murphy (ORCID: https://orcid.org/0000-0002-5738-2156)
- Breana Channer (ORCID: https://orcid.org/0000-0003-2461-4894)
- Katy Emanuel (ORCID: https://orcid.org/0000-0002-1001-3505)
- Howard S. Fox (ORCID: https://orcid.org/0000-0003-2032-374X)
- Yash Agarwal
- Marzieh Daniali
- Lexi Sheldon
- Taylor Kist
Institutions
- Nebraska Medical Center (US)
- University of Nebraska Medical Center (US)
- Drexel University (US)
Publication Details
- Journal
- Journal of Leukocyte Biology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1093/jleuko/qiaf071
- Citations
- 1
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Drexel University
- College of Medicine, Drexel University